Presidential Lecture Returns After COVID-19 Hiatus
Following two years when safety concerns related to the COVID-19 pandemic prevented in-person events on campus, on June 15, 2022, Montefiore and Einstein were again able to hold their fourth Einstein-Montefiore Presidential Lecture.
Established in 2017, the event features presentations by two faculty members who together represent outstanding examples of the full spectrum of research at Einstein and Montefiore, highlighting its excellence. Nearly 150 attended either the in-person event or virtually via Zoom. Robbins Auditorium offered ample seating where attendees could be safely spaced.
This year’s lecturers were Ulrich “Uli” Steidl, M.D., Ph.D., professor of cell biology and of medicine, deputy director of the Montefiore Einstein Cancer Center (MECC), and interim director of the Ruth L. and David S. Gottesman Institute for Stem Cell Biology and Regenerative Medicine, and Amit Verma, M.B.B.S., professor of medicine and of developmental and molecular biology, associate director of translational science at MECC, and director of the division of hemato-oncology at Montefiore and Einstein.
Over the past decade, Drs. Steidl and Verma have coauthored several dozen peer-reviewed papers published in high-quality journals, adding immensely to the understanding of two closely intertwined diseases: myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). They were among the first researchers to demonstrate that MDS, a common precursor of AML, arises from wayward bone-marrow stem cells, raising hopes for treating or preventing both diseases.
Drs. Ulrich Steidl and Amit Verma delivered presentations on their work at this year’s Presidential Lecture
Dr. Steidl discussed “Understanding the Molecular and Cellular Pathogenesis of Myeloid Malignancies at the Stem Cell Level,” and Dr. Verma presented “Therapeutic Targeting of MDS and AML.” You can tune into their presentations here.
Posted on: Monday, June 27, 2022